Select Page

Home / Share Price Target / Vivimedlab

Vivimed Labs Share Price Target 2024, 2025, 2026 to 2039 With Charts

Vivimed Labs Limited

Company LogoSymbol: VIVIMEDLAB
Price: ₹4.95
Exchange: NSE
Healthcare -> Drug Manufacturers - Specialty & Generic
Show Table of Contents

Vivimed Labs Brief Company Overview

Vivimed Labs Limited: A Comprehensive Overview

Established in 1988, Vivimed Labs Limited is a leading manufacturer of pharmaceuticals and specialty chemicals. With operations in India and exports worldwide, Vivimed has carved a niche in the industry with its diverse product range and commitment to innovation.

Key Products and Services:
  • Active pharmaceutical ingredients (APIs) for generic and ethical companies
  • Finished dosage formulations for ophthalmic, nutraceuticals, dermatology, and pain segments
  • Contract manufacturing for various formulations
  • Specialty chemicals for hair dye and photochromic applications
  • 'Favulous' tablets for Covid-19 treatment
Industry Reputation and Market Presence: Vivimed Labs is recognized for its commitment to quality and its vast product portfolio. The company has established a strong presence in India and exports to global markets.Conclusion: Vivimed Labs Limited stands as a trusted name in the healthcare and specialty chemicals industries. With its focus on innovation and diverse product range, the company is poised for continued success.

Vivimed Labs Financial Performance

MetricValueDescription
Market Capital40.62 CroreMarket valuation of Vivimed Labs's shares.
Revenue (TTM)150.51 CroreTotal revenue generated by Vivimed Labs over the past twelve months.
Net Income (TTM)-316.69 CroreNet Profit or Loss after all the expenses over the past twelve months.
Operating Margin-8.18%Income from operations as a percentage of revenue, before taxes and interest.
Profit Margin-210.41%Net income as a percentage of revenue, after all expenses.
Revenue Growth
(Quarterly)
-25.6%Change in revenue compared to the previous quarter.
Debt-to-Equity
(D/E) Ratio
180.85Company's total debt divided by total shareholder equity.
Total Debt319.69 CroreSum of Vivimed Labs's current & long-term financial obligations.
Total Cash2.27 CroreTotal amount of liquid funds available to Vivimed Labs.
Beta1.04Beta is greater than 1 indicating that the Vivimed Labs's price is more volatile than the market.

Is Vivimed Labs A Good Buy For Long Term?

Vivimed Labs, a smallcap stock with a market cap of 40.62 Crore, has a negative profit margin of -210.41% and a high debt of 319.69 Crore. Its revenue has declined by 25.6% in the last quarter. Over the past 12 months, the stock has performed poorly with negative returns of -23.85%. Considering these factors, this stock may not be a good buy for long-term investment.

To predict the Vivimed Labs's future market prices, we harnessed 2 dynamic approaches:

Approach 1: Technical Analysis Paired With Price Action
Approach 2: Machine Learning By Studying Historical Prices

Approach 1: Technical Analysis Paired With Price Action

Vivimed Labs Share Price Target For 2024

Vivimed Labs Targets For 2024 Chart

The line chart displays the monthly closing prices of Vivimed Labs with a black line. The green line shows three potential target prices for 2024, while the red line indicates three potential Stop Loss levels.

For detailed target and stop loss values for Vivimed Labs shares in 2024, see the table below.

Vivimed Labs Share Price Target Table For 2024

Vivimed Labs's LevelsValueReason/Importance
2024 Target 35.10 (+3.03%)Price Action: Chart
2024 Target 25.00 (+1.01%)Price Action: Chart
2024 Target 14.95 (0%)Fibonacci Extension Level 199%
Current Price4.95Vivimed Labs's 1 share price as of Thu 07 Nov 2024
Stop Loss 14.95 (0%)Fibonacci Retracement Extended 82.6%
Stop Loss 24.85 (-2.03%)Price Action: Jul 2023 Low
Stop Loss 34.76 (-3.84%)Price Action: Chart

Summary: Vivimed Labs Share Price Prediction For 2024

In summary, Vivimed Labs has surged by ₹0.00, achieving a notable +0.00% increase from 1st January 2024 to 07 Nov 2024. Despite the setback, our analysis of Vivimed Labs for 2024 predicts an additional rise of 0% to 3.03% by the end of 2024 with three potential targets T1: 4.95, T2: 5.00, T3: 5.10. Stop Loss at SL1: 4.95, SL2: 4.85, SL3: 4.76.

Vivimed Labs has a 52-week high of ₹4.95, acting as a crucial resistance level - a ceiling that could challenge further price increase. Conversely, it has a 52-week low of ₹4.95, a critical support level - think of this as a safety net where the price might stop falling.

After looking at 2024's share price prediction, let's now check what 2025 might hold for Vivimed Labs.

Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!

Join our WhatsApp group

Join our Telegram group

Your phone number will be HIDDEN to other users.

Vivimed Labs Share Price Target For 2025

Vivimed Labs Targets For 2025 Chart

The line chart displays the monthly closing prices of Vivimed Labs with a black line. The green line shows three potential target prices for 2025, while the red line indicates three potential Stop Loss levels.

For detailed target and stop loss values for Vivimed Labs shares in 2025, see the table below.

Vivimed Labs Share Price Target Table For 2025

Vivimed Labs's LevelsValueReason/Importance
2025 Target 35.10 (+3.03%)Price Action: Chart
2025 Target 25.00 (+1.01%)Price Action: Chart
2025 Target 14.95 (0%)Fibonacci Extension Level 199%
Current Price4.95Vivimed Labs's 1 share price as of Thu 07 Nov 2024
Stop Loss 14.95 (0%)Fibonacci Retracement Extended 82%
Stop Loss 24.85 (-2.03%)Price Action: Jul 2023 Low
Stop Loss 34.76 (-3.84%)Price Action: Chart

Summary: Vivimed Labs Share Price Prediction For 2025

In summary, Vivimed Labs has surged by ₹0.00, achieving a notable +0.00% increase from 1st January 2024 to 07 Nov 2024. Despite the setback, our analysis of Vivimed Labs for 2025 predicts an additional rise of 0% to 3.03% by the end of 2025 with three potential targets T1: 4.95, T2: 5.00, T3: 5.10. Stop Loss at SL1: 4.95, SL2: 4.85, SL3: 4.76.

Vivimed Labs has a All-Time high of ₹248.80, acting as a crucial resistance level - a ceiling that could challenge further price increase. Conversely, it has a 52-week low of ₹4.95, a critical support level - think of this as a safety net where the price might stop falling.

After looking at 2024's and 2025's share price prediction, you might wonder what are short term targets for Vivimed Labs, we have created a specific page for that check here: Vivimed Labs Share Price Target For Tomorrow & Next Week

Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!

Join our WhatsApp group

Join our Telegram group

Your phone number will be HIDDEN to other users.

Approach 2: Machine Learning By Studying Historical Prices

Vivimed Labs Long Term Share Price Prediction Chart From 2024, 2025, 2026 to 2039

Vivimed Labs Targets Chart 2024, 2025, 2026 to 2039

This chart presents a detailed projection of Vivimed Labs share price predictions from 2024, 2025, 2026 to 2039. This share price Prediction represents a CAGR of -0.44% over the next 15 years.

For complete year by year Vivimed Labs long term share price target from 2024, 2025 to 2039 check the below table.

Vivimed Labs Share Price Target Table From 2024, 2025, 2026 to 2039

YearVivimed Labs TargetYoY Change %
2024₹4.95[Current Price]
2024₹5.37.07%
2025₹5.01-5.48%
2026₹4.82-3.8%
2027₹4.932.28%
2028₹5.185.07%
2029₹5.373.66%
2030₹5.07-5.59%
2031₹4.88-3.75%
2032₹4.992.25%
2033₹5.255.21%
2034₹5.443.61%
2035₹5.14-5.52%
2036₹4.94-3.9%
2037₹5.052.22%
2038₹5.325.34%
2039₹4.98-6.4%

Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!

Join our WhatsApp group

Join our Telegram group

Your phone number will be HIDDEN to other users.

Vivimed Labs Past Performance

VIVIMEDLAB main
Vivimed Labs has been listed on NSE for more than 19 years.
  • In 2005, Vivimed Labs opening price was ₹40.6
  • As of Thu 07 Nov 2024 the price stands at ₹4.95.
  • This represents a Compound Annual Growth Rate (CAGR) of -9.99%.
  • In 19 years, an investment of 10,000 would have become ₹1,219.21.

As we wrap up, we hope you like our study on Vivimed Labs share price predictions, please kindly note that these forecasts are based on technical analysis, past trends, and machine learning models. They are for educational purposes only, not investment advice.

Show Methodology We Use

Methodology Behind the Prediction

The share price predictions present on our site are derived from a robust model that incorporates multiple economic indicators, technical indicators, company performance metrics, and industry-specific factors.

We have historical share price data of all stocks for which we present targets, so we analyse historical trends from those past data and overlay them with projected market conditions to estimate future share prices of a stock.

For more insights into Vivimed Labs Limited, explore these additional resources:-

Disclaimer: Information is provided 'as is' and solely for informational and educational purposes, not for trading purposes or advice. We highly recommend to do your own research before making any investment.

About The Author

Nippun

Hi, I’m Nippun, a tech enthusiast from Haryana, India. I have been coding since 2010 and using my coding skills in the share market since 2020. I have been coding scripts in Pinescript that work on Tradingview app/web. I love learning about new technology and applying it to solve real-world problems. Coding and share-market are my passions, and I enjoy finding and fixing bugs in code. I aim to share my skill set and experience that can positively impact society. Feel free to connect with me, and let’s learn from each other. My Twitter